文献速递儿科与产科急症消化、代谢与肾脏急症

急诊科儿童患者酮咯酸上限剂量效应的评估

Evaluation of ketorolac ceiling dose effects in pediatric patients in the emergency department.
PubMed 文献 · Am J Emerg Med · 2024-12-14
一句话结论回顾性研究显示,急诊儿童使用静脉酮咯酸15 mg与大于15 mg的镇痛效果相似,疼痛评分下降人数无统计学显著差异(p=0.84)。

该单中心回顾性观察研究纳入2021年7月至2022年7月在急诊科因急性疼痛接受静脉酮咯酸单药镇痛、最小剂量15 mg的儿童患者599例,比较15 mg与大于15 mg剂量的镇痛效果。主要结局为疼痛评分下降,两组疼痛评分下降人数无统计学显著差异(p=0.84)。作者认为,在急诊儿童中,静脉酮咯酸上限剂量15 mg与更大剂量的镇痛效果相似。

要点

  • 急诊儿童急性疼痛接受静脉酮咯酸单药镇痛时,15 mg与大于15 mg剂量的疼痛评分下降人数无统计学显著差异(p=0.84)。
  • 研究纳入599例急诊儿童患者,两组基线人口学特征相似。
  • 标准剂量按体重计算、上限30 mg,该上限高于成人常用最大剂量。
  • 作者认为,急诊儿童使用静脉酮咯酸上限剂量15 mg与更大剂量的镇痛效果相似。

适用人群与场景

  • 2021年7月至2022年7月在急诊科就诊、因急性疼痛接受静脉酮咯酸单药镇痛、最小剂量15 mg的儿童患者。

研究设计与关键结果

  • 研究类型为单中心回顾性观察研究,在儿童三级学术医疗中心开展,纳入599例急诊儿童患者,两组基线人口学特征相似。
  • 主要结局为接受单次静脉酮咯酸15 mg与大于15 mg剂量的疼痛评分变化,两组疼痛评分下降人数无统计学显著差异(p=0.84)。

证据类型、等级与局限

  • 证据类型:单中心回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在急诊儿童中,静脉酮咯酸上限剂量15 mg与更大剂量的镇痛效果相似。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The use of ketorolac for analgesia in the emergency department is a common practice for pediatric patients. There is a lack of guidance on optimal dosing to limit the risk of side effects especially in pediatric patients. The standard dosing is weight based with a cap at 30 mg, a dose which is higher than the typical max used for adult patients. The objective of this study is to compare the analgesic effect of intravenous ketorolac at doses of 15 mg versus doses greater than 15 mg.

METHODS: This retrospective observational study was performed at a single-center, pediatric tertiary academic medical center. A system-generated report identified patients with an order for IV ketorolac within the ED from July 2021 to July 2022. Pediatric patients presenting to the ED with acute pain and being treated with monotherapy ketorolac for analgesia at a minimum dose of 15 mg were included. The primary outcome of this study evaluated the change in pain score in patients receiving one dose of ketorolac dosed at 15 mg as compared to doses greater than 15 mg.

RESULTS: Our study population included 599 patients receiving ketorolac IV in the ED with baseline demographics similar between groups. For the primary outcome there was no statistically significant difference in the number of patients with a decrease in pain score between patient groups (p = 0.84).

CONCLUSION: This retrospective review demonstrates an association of similar analgesic effects using a capped dose of 15 mg of IV ketorolac as compared to larger doses in pediatric patients admitted to the ED.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Bindseil I, Soderstrom R, Balmat R, et al. Evaluation of ketorolac ceiling dose effects in pediatric patients in the emergency department. Am J Emerg Med. 2024. PMID: 39729680. doi:10.1016/j.ajem.2024.12.011

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。